Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by State Street Corp

State Street Corp raised its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 2.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,693,982 shares of the company's stock after acquiring an additional 88,922 shares during the quarter. State Street Corp owned approximately 1.99% of Doximity worth $160,947,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in DOCS. Morse Asset Management Inc acquired a new position in Doximity in the 3rd quarter valued at $46,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Doximity during the third quarter worth $308,000. Comprehensive Financial Management LLC acquired a new stake in shares of Doximity in the third quarter valued at about $7,704,000. Point72 Hong Kong Ltd purchased a new position in shares of Doximity in the third quarter worth about $137,000. Finally, Verition Fund Management LLC lifted its stake in shares of Doximity by 7.8% in the third quarter. Verition Fund Management LLC now owns 42,812 shares of the company's stock worth $1,865,000 after buying an additional 3,088 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Trading Down 1.1 %

Doximity stock traded down $0.56 during trading on Friday, hitting $52.14. The company had a trading volume of 1,467,088 shares, compared to its average volume of 1,750,562. The stock has a market cap of $9.73 billion, a price-to-earnings ratio of 59.93, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The company's 50 day simple moving average is $48.05 and its 200-day simple moving average is $37.88.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent research reports. The Goldman Sachs Group started coverage on shares of Doximity in a report on Friday, November 15th. They issued a "neutral" rating and a $58.00 price objective for the company. Robert W. Baird increased their price target on Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a report on Tuesday, September 17th. Bank of America boosted their price objective on Doximity from $32.00 to $45.00 and gave the stock a "neutral" rating in a research note on Monday, October 7th. Canaccord Genuity Group downgraded Doximity from a "buy" rating to a "hold" rating and raised their target price for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Finally, Raymond James reissued an "outperform" rating and set a $65.00 price target (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. Twelve research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $52.44.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.